Peter Bernhardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Bernhardt has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Oliver Strohm
MRI-Center at the St.-Gertrauden Hospital, Berlin, Germany
4 shared publicationsBerndt Lüderitz
3 shared publicationsHarald Schmidt
St. Marien‐Hospital Bonn, Bonn, Germany
3 shared publicationsHeyder Omran
St. Marien‐Hospital Bonn, Bonn, Germany
3 shared publicationsThomas Engels
MRI-Center at the St.-Gertrauden Hospital, Berlin, Germany
3 shared publicationsAlexander Albrecht
Private cardiology practice and catheterization center, Berlin, Germany
2 shared publications
Latest Publications
- Open Access
- 19 May 2009
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (13) , 1655
Cardiac metastasis of a gastric adenocarcinoma
A 76-year-old male was presented for artificial hip operation due to extensive arthrosis and reduced walking distance caused by pain. As the patient reports to suffer occasionally from palpitations on admission, further cardiologic examination is planned before the operation. On conventional transthoracic echocardiography, a mass of unknown origin is seen in the left atrium. Multi-slice thoracic computed tomography revealed a mass adjacent to the heart of unknown origin with a diameter of 60 mm (Panel A). Thus, the patient is referred for further evaluation by cardiac magnetic resonance (CMR) imaging.
- 19 May 2009
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (13) , 1655
Open AccessCardiac metastasis of a gastric adenocarcinoma
A 76-year-old male was presented for artificial hip operation due to extensive arthrosis and reduced walking distance caused by pain. As the patient reports to suffer occasionally from palpitations on admission, further cardiologic examination is planned before the operation. On conventional transthoracic echocardiography, a mass of unknown origin is seen in the left atrium. Multi-slice thoracic computed tomography revealed a mass adjacent to the heart of unknown origin with a diameter of 60 mm (Panel A). Thus, the patient is referred for further evaluation by cardiac magnetic resonance (CMR) imaging.
- 30 December 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 121 (3) , 261-266
Detection of cardiac small vessel disease by adenosine-stress magnetic resonance
- 30 December 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 121 (3) , 261-266
Detection of cardiac small vessel disease by adenosine-stress magnetic resonance
- 1 September 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 112 (2) , 184-190
Prediction of necessity for coronary artery revascularization by adenosine contrast-enhanced magnetic resonance imaging
- 1 September 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 112 (2) , 184-190
Prediction of necessity for coronary artery revascularization by adenosine contrast-enhanced magnetic resonance imaging
- 28 July 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 111 (1) , 86-91
Cardiac magnetic resonance in outpatients in Germany—indications, complications and protocol suggestions from a high-volume center
- 28 July 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 111 (1) , 86-91
Cardiac magnetic resonance in outpatients in Germany—indications, complications and protocol suggestions from a high-volume center
- 1 July 2006
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 8 (3) , 475-478
Safety of Adenosine Stress Magnetic Resonance Imaging Using a Mobile Cardiac Magnetic Resonance System
Background: Contrast-enhanced magnetic resonance imaging (ceMRI) allows for the detection of ischemic heart disease. Aim of this prospective study was to show feasibility, practicability and safety of adenosine stress ceMRI in routine outpatients with a mobile scanner. Methods: Consecutive patients were scanned in six different cardiac outpatient centers with a 1.5 T mobile ceMRI scanner. First-pass wash-in patterns of gadolinium chelate were evaluated after three minutes of adenosine infusion. After a second bolus of gadolinium chelate myocardial late enhancement (MLE) images of the left ventricle were acquired to visualize myocardial necrosis. Results: Five hundred seventy-four patients were enrolled to the study. No major complications during examination and adenosine infusion were observed. One hundred seventy-three minor complications as temporary atrio-ventriculare blockade, mild chest pain or dyspnea and nausea were noticed. None of the complications led to further special treatment Conclusion: This ceMRI protocol is suitable for application in outpatient settings. CeMRI stress testing using a mobile scanner in an outpatient setting is feasible and safe.
- 1 July 2006
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 8 (3) , 475-478
Safety of Adenosine Stress Magnetic Resonance Imaging Using a Mobile Cardiac Magnetic Resonance System
Background: Contrast-enhanced magnetic resonance imaging (ceMRI) allows for the detection of ischemic heart disease. Aim of this prospective study was to show feasibility, practicability and safety of adenosine stress ceMRI in routine outpatients with a mobile scanner. Methods: Consecutive patients were scanned in six different cardiac outpatient centers with a 1.5 T mobile ceMRI scanner. First-pass wash-in patterns of gadolinium chelate were evaluated after three minutes of adenosine infusion. After a second bolus of gadolinium chelate myocardial late enhancement (MLE) images of the left ventricle were acquired to visualize myocardial necrosis. Results: Five hundred seventy-four patients were enrolled to the study. No major complications during examination and adenosine infusion were observed. One hundred seventy-three minor complications as temporary atrio-ventriculare blockade, mild chest pain or dyspnea and nausea were noticed. None of the complications led to further special treatment Conclusion: This ceMRI protocol is suitable for application in outpatient settings. CeMRI stress testing using a mobile scanner in an outpatient setting is feasible and safe.
- 3 May 2006
- Published by Wiley in Echocardiography
- Vol. 23 (5) , 388-394
Atrial Thrombi—A Prospective Follow‐up Study over 3 Years with Transesophageal Echocardiography and Cranial Magnetic Resonance Imaging
Background: Patients with atrial fibrillation (AF) and atrial thrombi have an increased risk for cerebral embolism. However, there is little knowledge about the long‐term fate of atrial thrombi and the incidence of cerebral embolism in patients under oral anticoagulation. Methods: Consecutive patients with persistent or permanent AF and left atrial (LA) thrombi were included in the study. We performed serial and prospective transesophageal echocardiography, cranial magnetic resonance imaging, and clinical examinations during a period of 3 years. Oral anticoagulation was continued or initiated in all patients. A target INR of 2.5 was intended in all patients. Results: Forty‐three patients with LA thrombi and persistent or permanent AF were included. During the follow‐up period 31(72%) of the thrombi disappeared. Patients with disappearance of thrombi had significantly smaller thrombi (P < 0.01), a lower echogenicity of thrombi (P < 0.01), and a lower LA volume (P = 0.02). Twenty‐two (51%) patients suffered from cerebral embolism and/or death during the observation period. Five patients died due to embolic events. The only independent predictors of cerebral embolism were an elevated peak emptying velocity of the LA appendage (P < 0.001) and a history of previous thromboembolism (P < 0.01). Conclusions: Patients with persistent or permanent AF and atrial thrombi have a high long‐term risk of cerebral embolism and/or death (51%) even despite the oral anticoagulation therapy. Thrombus size may predict thrombus resolution under continued anticoagulation.
- 3 May 2006
- Published by Wiley in Echocardiography
- Vol. 23 (5) , 388-394
Atrial Thrombi—A Prospective Follow‐up Study over 3 Years with Transesophageal Echocardiography and Cranial Magnetic Resonance Imaging
Background: Patients with atrial fibrillation (AF) and atrial thrombi have an increased risk for cerebral embolism. However, there is little knowledge about the long‐term fate of atrial thrombi and the incidence of cerebral embolism in patients under oral anticoagulation. Methods: Consecutive patients with persistent or permanent AF and left atrial (LA) thrombi were included in the study. We performed serial and prospective transesophageal echocardiography, cranial magnetic resonance imaging, and clinical examinations during a period of 3 years. Oral anticoagulation was continued or initiated in all patients. A target INR of 2.5 was intended in all patients. Results: Forty‐three patients with LA thrombi and persistent or permanent AF were included. During the follow‐up period 31(72%) of the thrombi disappeared. Patients with disappearance of thrombi had significantly smaller thrombi (P < 0.01), a lower echogenicity of thrombi (P < 0.01), and a lower LA volume (P = 0.02). Twenty‐two (51%) patients suffered from cerebral embolism and/or death during the observation period. Five patients died due to embolic events. The only independent predictors of cerebral embolism were an elevated peak emptying velocity of the LA appendage (P < 0.001) and a history of previous thromboembolism (P < 0.01). Conclusions: Patients with persistent or permanent AF and atrial thrombi have a high long‐term risk of cerebral embolism and/or death (51%) even despite the oral anticoagulation therapy. Thrombus size may predict thrombus resolution under continued anticoagulation.
- 12 January 2006
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 95 (3) , 148-153
Atrial fibrillation—
Patients with atrial fibrillation (AF) have a risk of cerebral embolism. Echocardiographic parameters elevate this risk significantly. However, there is little knowledge about the long–term fate and the rate of clinically silent cerebral embolism under continued oral anticoagulation. The aims of our study were to assess prognosis of patients with AF and determine a high risk group with an increased risk of cerebral embolism under oral anticoagulation.
- 12 January 2006
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 95 (3) , 148-153
Atrial fibrillation—
Patients with atrial fibrillation (AF) have a risk of cerebral embolism. Echocardiographic parameters elevate this risk significantly. However, there is little knowledge about the long–term fate and the rate of clinically silent cerebral embolism under continued oral anticoagulation. The aims of our study were to assess prognosis of patients with AF and determine a high risk group with an increased risk of cerebral embolism under oral anticoagulation.